Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,212 | 537 | 63.2% |
| Consulting Fee | $3,528 | 3 | 18.3% |
| Travel and Lodging | $3,244 | 6 | 16.8% |
| Education | $329.02 | 20 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $4,772 | 27 | $0 (2024) |
| Inspire Medical Systems, Inc. | $2,577 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,022 | 90 | $0 (2024) |
| ZOLL Respicardia, Inc. | $1,756 | 3 | $0 (2024) |
| Mylan Specialty L.P. | $1,350 | 74 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,308 | 72 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,104 | 68 | $0 (2024) |
| United Therapeutics Corporation | $793.86 | 55 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $442.25 | 27 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $376.64 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,390 | 208 | Actelion Pharmaceuticals US, Inc. ($4,705) |
| 2023 | $2,457 | 117 | GlaxoSmithKline, LLC. ($368.20) |
| 2022 | $4,668 | 134 | Inspire Medical Systems, Inc. ($2,317) |
| 2021 | $1,797 | 107 | GlaxoSmithKline, LLC. ($434.16) |
All Payment Transactions
566 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| Category: Medical Device | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/11/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Consulting Fee | Cash or cash equivalent | $3,177.50 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $123.26 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Travel and Lodging | Cash or cash equivalent | $105.01 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | Cash or cash equivalent | $32.29 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 565 | 1,395 | $212,009 | $78,967 |
| 2022 | 12 | 558 | 1,468 | $212,629 | $78,153 |
| 2021 | 14 | 499 | 1,252 | $175,240 | $65,365 |
| 2020 | 11 | 418 | 1,117 | $174,412 | $61,763 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 445 | $94,232 | $33,423 | 35.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 565 | $74,371 | $28,372 | 38.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 114 | $22,623 | $8,746 | 38.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 39 | 41 | $7,786 | $3,044 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $5,640 | $2,066 | 36.6% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 23 | 36 | $2,556 | $1,385 | 54.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,394 | $658.37 | 27.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 61 | 80 | $1,165 | $655.62 | 56.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 29 | 42 | $756.00 | $341.22 | 45.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 37 | 37 | $486.00 | $275.18 | 56.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 61 | 709 | $88,040 | $32,861 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 247 | 428 | $89,423 | $32,332 | 36.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 43 | 94 | $16,752 | $6,256 | 37.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 37 | 37 | $6,732 | $2,523 | 37.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 19 | 23 | $3,364 | $1,167 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $3,524 | $1,141 | 32.4% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2022 | 16 | 20 | $1,420 | $772.57 | 54.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 19 | 20 | $1,500 | $418.25 | 27.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 24 | 26 | $364.00 | $198.90 | 54.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 53 | 65 | $650.00 | $191.94 | 29.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 15 | 21 | $378.00 | $175.03 | 46.3% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 12 | 13 | $482.00 | $116.93 | 24.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 89 | 582 | $73,908 | $27,574 | 37.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 157 | 296 | $61,293 | $22,260 | 36.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 52 | 115 | $20,804 | $7,835 | 37.7% |
About Christopher Gessel, NP
Christopher Gessel, NP is a Family healthcare provider based in Salem, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1851732655.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Gessel, NP has received a total of $19,312 in payments from pharmaceutical and medical device companies, with $10,390 received in 2024. These payments were reported across 566 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($12,212).
As a Medicare-enrolled provider, Gessel has provided services to 2,040 Medicare beneficiaries, totaling 5,232 services with total Medicare billing of $284,248. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Salem, UT
- Active Since 07/10/2013
- Last Updated 11/27/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1851732655
Products in Payments
- OPSUMIT (Drug) $4,500
- Inspire Upper Airway Stimulation System (Device) $2,317
- remede System (Device) $1,756
- GLASSIA (Biological) $1,104
- YUPELRI (Drug) $724.88
- FASENRA (Biological) $723.06
- TRELEGY ELLIPTA (Drug) $701.50
- DUPIXENT (Biological) $691.38
- BREZTRI (Drug) $648.17
- Yupelri (Drug) $625.02
- TEZSPIRE (Biological) $464.77
- TYVASO (Drug) $431.94
- Adempas (Drug) $376.64
- NUCALA (Biological) $352.95
- STIOLTO RESPIMAT (Drug) $348.25
- LUMRYZ (Drug) $347.45
- UPTRAVI (Drug) $272.63
- INSPIRE (Device) $259.77
- WAKIX (Drug) $198.55
- WINREVAIR (Biological) $196.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Salem
Pamela Price, Np, NP
Family — Payments: $15,044
Neeta Vorst, Fnp, FNP
Family — Payments: $14,287
Mrs. Kelli Farm, Np, NP
Family — Payments: $12,377
Mrs. Kelly Link, Np-C, NP-C
Family — Payments: $8,038
Mrs. Beth Hite, Np-C, NP-C
Family — Payments: $6,450
Sarah Markwood, Fnp, FNP
Family — Payments: $4,890